Redefining tumour suppressor genes: exceptions to the two-hit hypothesis

被引:39
作者
Paige, AJW [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Ctr Canc Res, Edinburgh EH4 2XR, Midlothian, Scotland
关键词
cancer; tumour suppressor genes; Knudson two-hit hypothesis; haploinsufficiency; hypermethylation;
D O I
10.1007/s00018-003-3027-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knudson's two-hit model of tumour suppressor genes supposes that two mutations are required to cause a turnout, one occurring in each of the two alleles of the gene. Many such cancer genes exhibiting biallelic disruption and truncating point mutations have been identified, revealing the success of the model. Despite changes in our concept of cancer genes, two inactivating point mutations are still considered the hallmark of tumour suppressor genes. Recently, however, more and more reports describe candidate tumour suppressors that do not conform to this standard definition, including haploinsufficient genes requiring inactivation of only one allele, and genes inactivated not by mutation but rather epigenetic hypermethylation. This review describes some of these exceptions and proposes a revised tumour suppressor gene definition to facilitate the identification of this new generation of tumour suppressor loci.
引用
收藏
页码:2147 / 2163
页数:17
相关论文
共 141 条
[1]   Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer [J].
Akiyama, Y ;
Iwanaga, R ;
Saitoh, K ;
Shiba, K ;
Ushio, K ;
Ikeda, E ;
Iwama, T ;
Nomizu, T ;
Yuasa, Y .
GASTROENTEROLOGY, 1997, 112 (01) :33-39
[2]  
Akiyama Y, 1997, CANCER RES, V57, P3920
[3]   2 HIT AND MULTIPLE HIT THEORIES OF CARCINOGENESIS [J].
ASHLEY, DJB .
BRITISH JOURNAL OF CANCER, 1969, 23 (02) :313-+
[4]   Cancer - New-age tumour suppressors [J].
Balmain, A .
NATURE, 2002, 417 (6886) :235-237
[5]   Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5'''-P-1,P-3-triphosphate hydrolase [J].
Barnes, LD ;
Garrison, PN ;
Siprashvili, Z ;
Guranowski, A ;
Robinson, AK ;
Ingram, SW ;
Croce, CM ;
Ohta, M ;
Huebner, F .
BIOCHEMISTRY, 1996, 35 (36) :11529-11535
[6]  
Bednarek AK, 2000, CANCER RES, V60, P2140
[7]  
Bednarek AK, 2001, CANCER RES, V61, P8068
[8]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[9]   The Fanconi anaemia genome stability and tumour suppressor network [J].
Bogliolo, M ;
Cabré, O ;
Callén, E ;
Castillo, V ;
Creus, A ;
Marcos, R ;
Surrallés, J .
MUTAGENESIS, 2002, 17 (06) :529-538
[10]  
Calin GA, 2000, INT J CANCER, V89, P230, DOI 10.1002/1097-0215(20000520)89:3<230::AID-IJC4>3.0.CO